Abstract:The antineoplastic effects of docosahexaenoic acid-containing phosphatidylcholine (DHA-PC) and eicosapentaenoic acid-containing phosphatidylcholine (EPA-PC) were explored, and their underlying mechanisms in the human lung carcinoma 95D cells (95D cells) were investigated. After treatment of 95D cells with DHA-PC or EPA-PC, cell biological behaviors such as growth, adhesion, migration, and invasion were studied. Immunofluorescence and western blotting were carried out to assess underlying molecular mechanisms. Results showed that 95D cells proliferation and adherence in the DHA-PC or EPA-PC group were drastically inhibited than the control group. DHA-PC and EPA-PC suppressed the migration and invasion of 95D cells by disrupting intracellular F-actin, which drives cell movement. The protein expression of PPAR gamma was induced versus the control group. Furthermore, critical factors related to invasion, including matrix metallopeptidase 9 (MMP9), heparanase (Hpa), and vascular endothelial growth factor (VEGF), were drastically downregulated through the PPAR gamma/NF-kappa B signaling pathway. C-X-C chemokine receptor type 4 (CXCR4) and cofilin were significantly suppressed via DHA-PC and EPA-PC through the PPAR gamma/phosphatase and tensin homolog (PTEN)/serine-threonine protein kinase (AKT) signaling pathway. DHA-PC and EPA-PC reversed the PPAR gamma antagonist GW9662-induced reduction of 95D cells in migration and invasion capacity, suggesting that PPAR gamma was directly involved in the anti-metastasis efficacy of DHA-PC and EPA-PC. In conclusion, DHA-PC and EPA-PC have great potential for cancer therapy, and the antineoplastic effects involve the activation of PPAR gamma. EPA-PC showed more pronounced antineoplastic effects than DHA-PC, possibly due to the more robust activation of PPAR gamma by EPA-PC.

DHA- and EPA-Enriched Phosphatidylcholine Suppress Human Lung Carcinoma 95D Cells Metastasis via Activating the Peroxisome Proliferator-Activated Receptor

Dha/Epa-Enriched Phosphatidylcholine Suppresses Tumor Growth And Metastasis Via Activating Peroxisome Proliferator-Activated Receptor Gamma In Lewis Lung Cancer Mice

DHA/EPA-Enriched Phosphatidylcholine Suppresses Tumor Growth and Metastasis via Activating Peroxisome Proliferator-Activated Receptor γ in Lewis Lung Cancer Mice

Study on the Effects of the Different Polar Group of EPA-enriched Phospholipids on the Proliferation and Apoptosis in 95D Cells

Role of Docosahexaenoic Acid-Phosphatidylcholine Liposomes in Inhibiting Tumor Growth

Dihydroartemisinin sensitizes Lewis lung carcinoma cells to carboplatin therapy via p38 mitogen-activated protein kinase activation.

The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathway

Pronounced Enhancement in Radiosensitization of Esophagus Cancer Cultivated in Docosahexaenoic Acid via the PPAR - γ Activation

DHA regulates angiogenesis and improves the efficiency of CDDP for the treatment of lung carcinoma.

Anti-tumor Activities and Immune Regulation of Docosahexaenoic Acidphosphatidylcholine Liposomes in Mice Bearing S_(180)

Ω-3 Polyunsaturated Fatty Acids Inhibit the Proliferation of the Lung Adenocarcinoma Cell Line A549 in Vitro.

Lysophosphatidylcholine inhibits lung cancer cell proliferation by regulating fatty acid metabolism enzyme long-chain acyl-coenzyme A synthase 5.

Inhibitory Effect of Dihydroartemisinin on the Proliferation and Migration of Melanoma Cells and Experimental Lung Metastasis From Melanoma in Mice

Effects of eicosapentaenoic acid on the growth of human cholangiocarcinoma cell lines FRH-0201

Inhibition of DHA on colorectal tumor pathogenesis and expression of related genes

Docosahexaenoic Acid Serving As Sensitizing Agents and Gefitinib Resistance Revertants in EGFR Targeting Treatment

Docosahexaenoic Acid in the Inhibition of Tumor Cell Growth in Preclinical Models of Ovarian Cancer

Dha Increases The Anti-Tumor Effect Of Gefitinib On Non-Small Cell Lung Cancer With Egfr Mutations In Vitro

Transcriptomic Response of Breast Cancer Cells MDA-MB-231 to Docosahexaenoic Acid: Downregulation of Lipid and Cholesterol Metabolism Genes and Upregulation of Genes of the Pro-Apoptotic ER-Stress Pathway

Synergistic Effect of Eicosapentaenoic Acid and Cisplatin on A-549 Human Lung Cancer Cell Line

Docosahexaenoic acid-enriched phospholipids and eicosapentaenoic acid-enriched phospholipids inhibit tumor necrosis factor-alpha-induced lipolysis in 3T3-L1 adipocytes by activating sirtuin 1 pathways